242 related articles for article (PubMed ID: 24498291)
21. 2,3,4',5-tetrahydroxystilbene-2-O-β-D-glucoside exacerbates acetaminophen-induced hepatotoxicity by inducing hepatic expression of CYP2E1, CYP3A4 and CYP1A2.
Xu S; Liu J; Shi J; Wang Z; Ji L
Sci Rep; 2017 Nov; 7(1):16511. PubMed ID: 29184146
[TBL] [Abstract][Full Text] [Related]
22. Activation of phenacetin O-deethylase activity by alpha-naphthoflavone in human liver microsomes.
Nakajima M; Kobayashi K; Oshima K; Shimada N; Tokudome S; Chiba K; Yokoi T
Xenobiotica; 1999 Sep; 29(9):885-98. PubMed ID: 10548449
[TBL] [Abstract][Full Text] [Related]
23. In Silico Predictions of Drug - Drug Interactions Caused by CYP1A2, 2C9 and 3A4 Inhibition - a Comparative Study of Virtual Screening Performance.
Kaserer T; Höferl M; Müller K; Elmer S; Ganzera M; Jäger W; Schuster D
Mol Inform; 2015 Jun; 34(6-7):431-57. PubMed ID: 27490388
[TBL] [Abstract][Full Text] [Related]
24. Regioselectivity prediction of CYP1A2-mediated phase I metabolism.
Jung J; Kim ND; Kim SY; Choi I; Cho KH; Oh WS; Kim DN; No KT
J Chem Inf Model; 2008 May; 48(5):1074-80. PubMed ID: 18412330
[TBL] [Abstract][Full Text] [Related]
25. Exploring the structure characteristics and major channels of cytochrome P450 2A6, 2A13, and 2E1 with pilocarpine.
Fan JR; Li H; Zhang HX; Zheng QC
Biopolymers; 2018 Apr; 109(4):e23108. PubMed ID: 29484634
[TBL] [Abstract][Full Text] [Related]
26. Comparative Study of Binding Pockets in Human CYP1A2, CYP3A4, CYP3A5, and CYP3A7 with Aflatoxin B1, a Hepato-Carcinogen, by Molecular Dynamics Simulation & Principal Component Analysis.
Saba N; Seal A
Curr Drug Metab; 2022; 23(7):521-537. PubMed ID: 35850656
[TBL] [Abstract][Full Text] [Related]
27. Granzyme B and miR-378a Interaction in Acetaminophen Toxicity in Children.
McCullough S; Dweep H; McGill MR; Bhattacharyya S; James L; Frankowski S; Woodall A; Kearns G; Gill P
Microrna; 2020; 9(2):121-132. PubMed ID: 31393259
[TBL] [Abstract][Full Text] [Related]
28. Screening of Human CYP1A2 and CYP3A4 Inhibitors from Seaweed In Silico and In Vitro.
Yim SK; Kim K; Chun S; Oh T; Jung W; Jung K; Yun CH
Mar Drugs; 2020 Nov; 18(12):. PubMed ID: 33260381
[TBL] [Abstract][Full Text] [Related]
29. Simulation-Guided Design of Cytochrome P450 for Chemo- and Regioselective Macrocyclic Oxidation.
Petrović D; Bokel A; Allan M; Urlacher VB; Strodel B
J Chem Inf Model; 2018 Apr; 58(4):848-858. PubMed ID: 29522682
[TBL] [Abstract][Full Text] [Related]
30. Quantitative evaluation of bromodichloromethane metabolism by recombinant rat and human cytochrome P450s.
Allis JW; Zhao G
Chem Biol Interact; 2002 May; 140(2):137-53. PubMed ID: 12076521
[TBL] [Abstract][Full Text] [Related]
31. Dehydrogenation of indoline by cytochrome P450 enzymes: a novel "aromatase" process.
Sun H; Ehlhardt WJ; Kulanthaivel P; Lanza DL; Reilly CA; Yost GS
J Pharmacol Exp Ther; 2007 Aug; 322(2):843-51. PubMed ID: 17502430
[TBL] [Abstract][Full Text] [Related]
32. Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.
Sahi J; Black CB; Hamilton GA; Zheng X; Jolley S; Rose KA; Gilbert D; LeCluyse EL; Sinz MW
Drug Metab Dispos; 2003 Apr; 31(4):439-46. PubMed ID: 12642470
[TBL] [Abstract][Full Text] [Related]
33. Loss of CYP2E1 and CYP1A2 activity as a function of acetaminophen dose: relation to toxicity.
Snawder JE; Roe AL; Benson RW; Roberts DW
Biochem Biophys Res Commun; 1994 Aug; 203(1):532-9. PubMed ID: 8074700
[TBL] [Abstract][Full Text] [Related]
34. Structure-Based Site of Metabolism (SOM) Prediction of Ligand for CYP3A4 Enzyme: Comparison of Glide XP and Induced Fit Docking (IFD).
Lokwani DK; Sarkate AP; Karnik KS; Nikalje APG; Seijas JA
Molecules; 2020 Apr; 25(7):. PubMed ID: 32244772
[TBL] [Abstract][Full Text] [Related]
35. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.
Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK
Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18.
Minoletti C; Dijols S; Dansette PM; Mansuy D
Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023
[TBL] [Abstract][Full Text] [Related]
37. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
Wójcikowski J; Danek PJ; Basińska-Ziobroń A; Pukło R; Daniel WA
Pharmacol Rep; 2020 Jun; 72(3):612-621. PubMed ID: 32219694
[TBL] [Abstract][Full Text] [Related]
38. DR-predictor: incorporating flexible docking with specialized electronic reactivity and machine learning techniques to predict CYP-mediated sites of metabolism.
Huang TW; Zaretzki J; Bergeron C; Bennett KP; Breneman CM
J Chem Inf Model; 2013 Dec; 53(12):3352-66. PubMed ID: 24261543
[TBL] [Abstract][Full Text] [Related]
39. Probing the Role of the Hinge Segment of Cytochrome P450 Oxidoreductase in the Interaction with Cytochrome P450.
Campelo D; Esteves F; Brito Palma B; Costa Gomes B; Rueff J; Lautier T; Urban P; Truan G; Kranendonk M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563285
[TBL] [Abstract][Full Text] [Related]
40. Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes.
Laine JE; Auriola S; Pasanen M; Juvonen RO
Xenobiotica; 2009 Jan; 39(1):11-21. PubMed ID: 19219744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
